Vitamin A

Why It Matters for Longevity

Vitamin A is not a single molecule but a family of fat-soluble retinoids. Preformed retinol and its esterified storage form (retinyl palmitate) come from animal products and are absorbed at near-100% efficiency. Provitamin A carotenoids — beta-carotene, alpha-carotene, and beta-cryptoxanthin — are found in plant foods and converted to retinol in the intestinal epithelium, but conversion efficiency is highly variable: estimates range from 1% to 28% depending on food matrix, individual genetics, and fat intake. This distinction matters clinically because the two sources carry different risk profiles at high intakes.

Nuclear receptor signaling. The primary active metabolite, retinoic acid, acts through two families of nuclear receptors — retinoic acid receptors (RARα, β, γ) and retinoid X receptors (RXRα, β, γ). RXR heterodimerizes with multiple other nuclear receptors including vitamin D receptor (VDR), thyroid hormone receptor, and PPAR-γ, making vitamin A status a master modulator of gene programs governing immune cell differentiation, epithelial integrity, and cellular apoptosis. These are directly longevity-relevant pathways. Pino-Lagos et al. (2010) reviewed how retinoic acid drives naive T cells toward regulatory T cell (Treg) and Th2 phenotypes via RAR/RXR while suppressing pro-inflammatory Th17 differentiation — a mechanistic link between vitamin A status and autoimmune and inflammatory disease risk.

Immune function. Stephensen (2001) reviewed the evidence on vitamin A, infection, and immune function, documenting that vitamin A deficiency impairs both innate and adaptive immunity through at least two independent pathways. First, it impedes the regeneration of mucosal barrier epithelium damaged by infection, increasing pathogen translocation. Second, it reduces neutrophil, macrophage, and NK cell function and diminishes Th2-mediated antibody responses. These immunological impairments account for the increased morbidity and mortality seen in vitamin A-deficient children and pregnant women in low-income settings, where vitamin A supplementation trials have demonstrated a 30% reduction in all-cause mortality in children (Stephensen, 2001, Annu Rev Nutr).

Alzheimer's disease associations. Alzheimer's disease patients have lower serum levels of beta-carotene and vitamin A compared to controls. Jiménez-Jiménez et al. (1999) found that serum beta-carotene and vitamin A were significantly lower in Alzheimer's patients. Ono and Yamada (2012) reviewed converging evidence that retinoic acid signaling supports neurogenesis and clearance of amyloid-beta via RAR-dependent transcription, while vitamin A deficiency accelerates brain aging through impaired neuronal differentiation and antioxidant defense.

The CARET trial — a critical cautionary finding. The most important safety signal in vitamin A research comes from CARET (Beta-Carotene and Retinol Efficacy Trial), a large RCT testing daily supplements of 30 mg beta-carotene plus 25,000 IU retinyl palmitate in 18,314 smokers, former smokers, and asbestos-exposed workers. The trial was halted 21 months early when an interim analysis showed that active-treatment participants had a relative risk of lung cancer of 1.28 (95% CI: 1.04–1.57) — 28% more lung cancers — and all-cause mortality was 17% higher (RR 1.17). Cardiovascular mortality was also elevated (RR 1.26). The mechanism remains debated; one hypothesis is that excess beta-carotene in high-oxidative-stress environments (cigarette smoke) generates pro-oxidant cleavage products that disrupt retinoid signaling and promote aberrant cell proliferation (Omenn et al., 1996, N Engl J Med). This finding underscores that supplemental beta-carotene at pharmacological doses is not a safe proxy for dietary vitamin A in high-risk populations.

Teratogenicity at high preformed doses. Preformed vitamin A (retinol, retinyl esters) is teratogenic at doses exceeding the safe upper limit. Rothman et al. (1995) analyzed 22,748 pregnant women and found that supplemental vitamin A intake above 10,000 IU/day was associated with an approximately 4.8-fold higher prevalence of cranial neural crest defects (95% CI: 2.2–10.5) compared to intakes ≤5,000 IU/day. The critical exposure window was before the seventh week of gestation. Approximately 1 in 57 infants born to women consuming >10,000 IU/day of supplemental vitamin A had malformations attributable to the exposure. The UL for preformed vitamin A in adults is set at 3,000 mcg RAE/day (10,000 IU) for this reason. Beta-carotene from food carries no such risk because intestinal conversion to retinol is downregulated when liver stores are replete (Rothman et al., 1995, N Engl J Med).

Practical dietary range. Meeting the RDA (700–900 mcg RAE/day for adults) through food sources requires modest dietary diversity: 100 g cooked sweet potato provides ~960 mcg RAE; 100 g beef liver provides ~6,500 mcg RAE. The substantial liver value illustrates why regular high-dose liver consumption warrants attention for reproductive-age women. Carrots and leafy greens contribute large amounts of beta-carotene, but the variable conversion rate means plant sources alone may be inadequate for individuals with low dietary fat intake or genetic polymorphisms affecting BCO1 enzyme activity.

How to Use It

Pairs well with olive oil, salmon, sweet potato. Use as a nutrient in your daily meals according to the Longevity Diet guidelines. Fat co-ingestion is essential for absorption of both retinol and carotenoids; consuming beta-carotene-rich vegetables with olive oil meaningfully increases bioavailability.

What to Pair It With

Synergies

• Vitamin E (synergy): Both fat-soluble vitamins commonly deficient in US adults per the book; taken together in a multivitamin maximizes fat-soluble vitamin coverage.
• Vitamin D (synergy): Vitamin A and D share nuclear receptor partners (RXR); balanced intake of both optimizes immune regulation and gene expression.
• Olive Oil (synergy): Dietary fat is essential for absorption of fat-soluble vitamin A; olive oil is the Longevity Diet's primary fat vehicle.

Flavor Profile

Category: micronutrient / supplement.

The Science

• Pino-Lagos et al., 2010, Biofactors: Retinoic acid drives Treg and Th2 differentiation while suppressing pro-inflammatory Th17 cells via RAR/RXR nuclear receptors — key mechanism linking vitamin A to inflammatory regulation.
• Stephensen, 2001, Annu Rev Nutr: Vitamin A deficiency impairs mucosal barrier regeneration and innate/adaptive immune function; supplementation reduces all-cause mortality in deficient children by ~30%.
• Ono & Yamada, 2012, Geriatr Gerontol Int: Reviews evidence that retinoic acid supports neurogenesis and amyloid-beta clearance; vitamin A deficiency may accelerate Alzheimer's disease pathogenesis.
• Jiménez-Jiménez et al., 1999, Eur J Neurol: Serum beta-carotene and vitamin A were significantly lower in Alzheimer's disease patients compared to age-matched controls.
• Omenn et al., 1996, N Engl J Med: CARET trial (n=18,314, mean 4 years): combined supplementation with 30 mg beta-carotene + 25,000 IU vitamin A increased lung cancer incidence 28% (RR 1.28) and all-cause mortality 17% (RR 1.17) in smokers and asbestos-exposed workers; trial halted early.
• Rothman et al., 1995, N Engl J Med: n=22,748 pregnant women; supplemental vitamin A >10,000 IU/day associated with 4.8-fold higher prevalence of cranial neural crest birth defects (95% CI: 2.2–10.5) versus ≤5,000 IU/day; threshold around 10,000 IU/day identified.

References

1. Pino-Lagos K, Guo Y, Noelle RJ. Retinoic acid: a key player in immunity. Biofactors. 2010;36(6):430-6. PMID: 20803520. doi:10.1002/biof.117
2. Stephensen CB. Vitamin A, infection, and immune function. Annu Rev Nutr. 2001;21:167-192. PMID: 11375434. doi:10.1146/annurev.nutr.21.1.167
3. Ono K, Yamada M. Vitamin A and Alzheimer's disease. Geriatr Gerontol Int. 2012;12(2):180-188. PMID: 22221326. doi:10.1111/j.1447-0594.2011.00786.x
4. Jiménez-Jiménez FJ, Molina JA, de Bustos F, et al. Serum levels of beta-carotene, alpha-carotene and vitamin A in patients with Alzheimer's disease. Eur J Neurol. 1999;6(4):495-497. PMID: 10362906. doi:10.1046/j.1468-1331.1999.640495.x
5. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334(18):1150-1155. PMID: 8602180. doi:10.1056/NEJM199605023341802
6. Rothman KJ, Moore LL, Singer MR, Nguyen US, Mannino S, Milunsky A. Teratogenicity of high vitamin A intake. N Engl J Med. 1995;333(21):1369-1373. PMID: 7477116. doi:10.1056/NEJM199511233332101

Key Nutrients